| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |